In granting the preliminary injunction motion, the district court evaluated (1) Natera’s likelihood of success on the merits of its infringement claim with respect to the ʼ035 patent; (2) the ...
Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...
Improving adequacy rates of bone marrow aspirate and core biopsies through training and a bedside X-ray device. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...